摘要
糖皮质激素具有强力高效的抗炎和免疫抑制作用,一直是预防、治疗肾移植排斥反应的关键药物。但糖皮质激素同时也具有明显的副作用,本文就其在肾移植中的合理应用进行简要综述。
参考文献10
-
1Horigome A,Hirano T,Oka K. British Journal of Clinical Pharmacology . 1999
-
2Sabatini S,Ferguson RM,Helderman JH. American Journal of Kidney Diseases . 1999
-
3Veeastra DL,Best JH,Hornberger J. American Journal of Kidney Diseases . 1999
-
4Kamath S,Dean D,Peddi VR. Transplantation . 1997
-
5Danovitch GM. Kidney International . 2002
-
6Ellis D. Pediatric Nephrology . 2000
-
7Nowacka CE,Durlik M,Cieciura T. Transplantation Proceedings . 2001
-
8Matl I,Lacha J,Lodererova A. Nephrology Dialysis Transplantation . 2000
-
9Mikuls TR,Julian BA. Transplantation . 2003
-
10Risch L,Herklotz R. Clinical Chemistry . 2001
同被引文献42
-
1王振,付迎欣.糖皮质激素在肾移植中的应用[J].实用器官移植电子杂志,2014,2(2):83-86. 被引量：4
-
2史燕军,贾瑞鹏.非糖皮质激素免疫抑制方案在肾移植中的研究进展[J].国际泌尿系统杂志,2006,26(1):76-79. 被引量：2
-
3Bergmann T K,Barraclough K A,Lee K J,et al.Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation[J].Clin Pharmacokinet,2012,51(11):711-741.
-
4Czock D,Keller F,Maximilian F,et al.Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids[J].Clin Pharmacokinet 2005,44(1):61-98.
-
5Jeng S,Chanchairujira T,Jusko W,et al.Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole[J].Transplantation,2003,75(6):792-795.
-
6Coutinho A E,Chapman K E.The anti-inflammatory and immunosuppressive effects of glucocorticoids,recent developments and mechanistic insights[J].Molecular Cellular Endocrinol,2011,335(1):2-13.
-
7Wieland E,Olbricht C J,Süsal C,et al.Biomarkers as a tool for management of immunosuppression in transplant patients[J].Ther Drug Monit,2010,32(5):560-572.
-
8Atalar K,Afzali B,Lord G,et al.Relative roles of Th1 and Th17effector cells in allograft rejection[J].Curr Opin Organ Transplant,2009,14(1):23-29.
-
9Millán O,Rafael-Valdivia L,TorrademéE,et al.Intracellular IFN-c and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients[J].Cytokine,2013,61(2):556-564.
-
10Gras J,Wieers G,Vaerman J L,et al.Early immunological monitoring after pediatric liver transplantation:cytokine immune deviation and graft acceptance in 40 recipients[J].Liver Transpl,2007,13(3):426-433.
引证文献3
-
1陈文倩,张相林.肾移植术后泼尼松/泼尼松龙的临床药动学/药效学研究进展[J].临床药物治疗杂志,2015,13(4):11-15. 被引量：4
-
2陈文倩,杜雯雯,王晓星,李朋梅,王晓雪,崔刚,张相林.糖皮质激素在器官移植中的临床应用进展[J].中国医院用药评价与分析,2016,16(7):871-873. 被引量：4
-
3满芯悦,徐虹.儿童肾移植免疫抑制治疗中激素应用的变迁[J].肾脏病与透析肾移植杂志,2017,26(5):486-490.
二级引证文献8
-
1曹增节.网络环境下公共信息资源对政府的意义[J].浙江经济,2000(5):44-45. 被引量：2
-
2冯润东,曹蕾,刘蕊,宋冰雪,刘静,曹永孝.活犀角与犀角抗惊厥作用的研究[J].安徽医药,2015,19(12):2284-2287. 被引量：1
-
3彭颖,黄桦,聂波,张瑶,柳汝明.基于群体药动学的环孢素A个体化给药研究进展[J].药学进展,2020,44(6):426-432. 被引量：4
-
4凡炼炼,郭义明,白凤芝,刘文平.肺炎并结缔组织相关疾病患者长期使用甲泼尼龙致激素性白内障1例[J].中国实验诊断学,2020,24(6):1030-1031.
-
5魏文斌,郭凡帆,林志健,张冰.器官移植患者的中药合理应用与临床用药警戒[J].中华中医药杂志,2021,36(1):103-105. 被引量：1
-
6叶慰乾,杨宏伟.肾移植术后激素撤除方案的临床研究[J].中国医学创新,2021,18(31):40-45. 被引量：2
-
7闫晗,刘颖,杨巧芝,吕学云,秦媛,秦道刚,刘培漫,王婷.LC-MS法测定人血清中泼尼松的浓度[J].吉林医药学院学报,2022,43(1):16-19.
-
8金立慧.熊去氧胆酸与免疫抑制剂联合治疗自身免疫性肝炎合并原发性胆汁性肝硬化的研究[J].现代消化及介入诊疗,2019,24(2):190-193. 被引量：22
-
1冯照晗,夏穗生,周平,李锦文,张肖红.用自制XZF液保存大鼠胰腺的实验研究[J].中华器官移植杂志,1997,18(2):91-92. 被引量：2
-
2王雪祥.前列腺疾病的防治[J].双足与保健,2006(2):38-39.
-
3尤平洪,卢一平.一种新型的IL-2R受体阻滞剂——抗CD25单克隆抗体[J].华西医学,2007,22(3):659-660. 被引量：7
